SAN DIEGO The Clearity Foundation announced the addition of John Brannelly as the regional director of development for Metro New York based out of Fairfield. Brannelly, a Fairfield resident, will be responsible for raising awareness and funds for the Clearity Foundation’s core programs to help women with ovarian cancer throughout the tri-state area. His experience and knowledge will help in the mobilization of volunteers and key community members in an effort to save more lives from ovarian cancer.

“John Brannelly will help us raise awareness and funds so we can help more patients, so every woman diagnosed with ovarian cancer can benefit from Clearity Foundation’s scientifically based programs,” stated Hillary Theakston, executive director of Clearity Foundation. “While we have therapists working in 10 states, it is the first time we putting dedicated development staff outside of California to help expand Clearity’s national scope,” Theakston added.

Clearity Foundation helps ovarian cancer patients and their physicians make better-informed treatment decisions to improve health outcomes. Clearity provides patient support services including molecular profiling and tumor blueprint interpretation, clinical trial identification, and its new psychosocial program, Steps Through OC — all free of charge.

An information session about Clearity Foundation’s free programs and services for ovarian cancer patients and caregivers is being held in Fairfield at the Gaelic American Club on Beach Road on Wednesday, Feb. 26 at 6:30 p.m.

People interested in learning more are encouraged to attend. It is free and open to the public.

Brannelly has worked for the American Cancer Society serving as director of major gifts for Connecticut and Westchester County and regional director of corporate relations in San Diego where he secured a $1 million gift. Most recently he worked for Hartford HealthCare St. Vincent’s Medical Center Foundation/SWIM Across the Sound overseeing its major gifts program.

The Clearity Foundation was founded by biotech industry veteran Dr. Laura Shawver, herself an ovarian cancer survivor, to revolutionize ovarian cancer treatment. Since inception, the nonprofit organization has provided hundreds of phone counseling consultations and molecular profiles to patients battling ovarian cancer.

Grounded in science, The Clearity Foundation’s research database of over 550 patients has been described as the largest of its kind and is a rich source of information that can be used to improve patient care in the future. To learn more or to make a donation, please visit http://www.clearity

foundation.org/support/

donate/